Diagnosis and differential diagnosis 
Gonococcal culture
Prevention 
Dr Erica Stewart, Centenary Institute[/caption]
Chelsea Felkai, MPS[/caption]
Working with the nursing staff to understand when PRN (as required) chemical restraint might be used, and ensuring other options have been exhausted first, has shown the most reduction in how much psychotropic medications have been used so far. The numbers are relatively small, but to be honest, this is largely because the facility had great protocols to begin with.
Dr Natalie Soulsby FPS[/caption]
Associate Professor Luke Grzeskowiak[/caption]
Expert advice for navigating R U OK? conversations
R U OK? Day (14 September) provides the perfect opportunity for pharmacists to check how patients are coping.
What happens now we know the cardiovascular risk calculator was wrong
AP examines what the new cardiovascular risk calculator means for patients and whether the wrong people are on preventive medicines.
Digital first
Andrew Matthews MPS is the Australian Digital Health Agency’s Director of Medicines Safety. In that role, he hopes to ensure pharmacists are fundamental to healthcare’s digital future.
Fostering cultural safety
There are a few simple techniques that can go a long way toward making transgender and gender-diverse patients, as well as all LGBTQIA+ people, feel welcome and respected.
2020: an unprecedented year in review
With a ferocious bushfire season that ravaged much of the country followed by the COVID-19 pandemic – pharmacists were on the frontline every step of the way.
Case study: Getting to the bottom of Rosa’s sleep problems
Allergic rhinitis (AR), commonly known as hayfever, affects around 19% of Australians. This case study explores how it impacts sleep quality.
